33946919|t|Oral Administration of Lactobacillus rhamnosus Ameliorates the Progression of Osteoarthritis by Inhibiting Joint Pain and Inflammation.
33946919|a|Osteoarthritis (OA) is the most common form of arthritis and age-related degenerative joint disorder, which adversely affects quality of life and causes disability. However, the pathogenesis of OA remains unclear. This study was performed to examine the effects of Lactobacillus rhamnosus in OA progression. OA was induced in 6-week-old male Wistar rats by monosodium iodoacetate (MIA) injection, and the effects of oral administration of L. rhamnosus were examined in this OA rat model. Pain severity, cartilage destruction, and inflammation were measured in MIA-induced OA rats. The small intestines were isolated from OA rats, and the intestinal structure and inflammation were measured. Protein expression in the dorsal root ganglion was analyzed by immunohistochemistry. The effects of L. rhamnosus on mRNA and protein expression in chondrocytes stimulated with interleukin (IL)-1beta and lipopolysaccharide (LPS) were analyzed by real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Pain severity was decreased in L. rhamnosus-treated MIA-induced OA rats. The levels of expression of MCP-1, a potential inflammatory cytokine, and its receptor, CCR2, were decreased, and GABA and PPAR-gamma expression were increased in L. rhamnosus-treated OA rats. The inflammation, as determined by IL-1beta, and cartilage destruction, as determined by MMP3, were also significantly decreased by L. rhamnosus in OA rats. Additionally, intestinal damage and inflammation were improved by L. rhamnosus. In human OA chondrocytes, TIMP1, TIMP3, SOX9, and COL2A1 which are tissue inhibitors of MMP, and IL-10, an anti-inflammatory cytokine, were increased by L. rhamnosus. L. rhamnosus treatment led to decreased pain severity and cartilage destruction in a rat model of OA. Intestinal damage and inflammation were also decreased by L. rhamnosus treatment. Our findings suggested the therapeutic potential of L. rhamnosus in OA.
33946919	23	46	Lactobacillus rhamnosus	Species	47715
33946919	78	92	Osteoarthritis	Disease	MESH:D010003
33946919	113	117	Pain	Disease	MESH:D010146
33946919	122	134	Inflammation	Disease	MESH:D007249
33946919	136	150	Osteoarthritis	Disease	MESH:D010003
33946919	152	154	OA	Disease	MESH:D010003
33946919	183	192	arthritis	Disease	MESH:D001168
33946919	209	236	degenerative joint disorder	Disease	MESH:D019636
33946919	330	332	OA	Disease	MESH:D010003
33946919	401	424	Lactobacillus rhamnosus	Species	47715
33946919	428	430	OA	Disease	MESH:D010003
33946919	444	446	OA	Disease	MESH:D010003
33946919	485	489	rats	Species	10116
33946919	493	515	monosodium iodoacetate	Chemical	MESH:D019807
33946919	517	520	MIA	Chemical	MESH:D019807
33946919	575	587	L. rhamnosus	Species	47715
33946919	610	612	OA	Disease	MESH:D010003
33946919	613	616	rat	Species	10116
33946919	624	628	Pain	Disease	MESH:D010146
33946919	639	660	cartilage destruction	Disease	MESH:D002357
33946919	666	678	inflammation	Disease	MESH:D007249
33946919	696	699	MIA	Chemical	MESH:D019807
33946919	708	710	OA	Disease	MESH:D010003
33946919	711	715	rats	Species	10116
33946919	757	759	OA	Disease	MESH:D010003
33946919	760	764	rats	Species	10116
33946919	799	811	inflammation	Disease	MESH:D007249
33946919	927	939	L. rhamnosus	Species	47715
33946919	1003	1025	interleukin (IL)-1beta	Gene	24494
33946919	1030	1048	lipopolysaccharide	Chemical	MESH:D008070
33946919	1050	1053	LPS	Chemical	MESH:D008070
33946919	1164	1168	Pain	Disease	MESH:D010146
33946919	1195	1207	L. rhamnosus	Chemical	-
33946919	1216	1219	MIA	Chemical	MESH:D019807
33946919	1228	1230	OA	Disease	MESH:D010003
33946919	1231	1235	rats	Species	10116
33946919	1265	1270	MCP-1	Gene	100360872
33946919	1284	1296	inflammatory	Disease	MESH:D007249
33946919	1325	1329	CCR2	Gene	60463
33946919	1351	1355	GABA	Chemical	MESH:D005680
33946919	1360	1370	PPAR-gamma	Gene	25664
33946919	1400	1412	L. rhamnosus	Species	47715
33946919	1421	1423	OA	Disease	MESH:D010003
33946919	1424	1428	rats	Species	10116
33946919	1434	1446	inflammation	Disease	MESH:D007249
33946919	1465	1473	IL-1beta	Gene	24494
33946919	1479	1500	cartilage destruction	Disease	MESH:D002357
33946919	1519	1523	MMP3	Gene	171045
33946919	1562	1574	L. rhamnosus	Species	47715
33946919	1578	1580	OA	Disease	MESH:D010003
33946919	1581	1585	rats	Species	10116
33946919	1601	1618	intestinal damage	Disease	MESH:D007410
33946919	1623	1635	inflammation	Disease	MESH:D007249
33946919	1653	1665	L. rhamnosus	Species	47715
33946919	1670	1675	human	Species	9606
33946919	1676	1678	OA	Disease	MESH:D010003
33946919	1693	1698	TIMP1	Gene	7076
33946919	1700	1705	TIMP3	Gene	7078
33946919	1707	1711	SOX9	Gene	6662
33946919	1717	1723	COL2A1	Gene	1280
33946919	1764	1769	IL-10	Gene	3586
33946919	1779	1791	inflammatory	Disease	MESH:D007249
33946919	1820	1832	L. rhamnosus	Species	47715
33946919	1834	1846	L. rhamnosus	Species	47715
33946919	1874	1878	pain	Disease	MESH:D010146
33946919	1892	1913	cartilage destruction	Disease	MESH:D002357
33946919	1919	1922	rat	Species	10116
33946919	1932	1934	OA	Disease	MESH:D010003
33946919	1936	1953	Intestinal damage	Disease	MESH:D007410
33946919	1958	1970	inflammation	Disease	MESH:D007249
33946919	1994	2006	L. rhamnosus	Species	47715
33946919	2070	2082	L. rhamnosus	Species	47715
33946919	2086	2088	OA	Disease	MESH:D010003
33946919	Association	MESH:D007249	100360872
33946919	Association	MESH:D010003	7076
33946919	Negative_Correlation	MESH:D007249	3586
33946919	Association	MESH:D010003	25664
33946919	Association	MESH:D005680	MESH:D010003
33946919	Association	MESH:D010003	7078
33946919	Association	MESH:D010003	100360872
33946919	Positive_Correlation	MESH:D019807	MESH:D010003
33946919	Association	MESH:D010003	1280
33946919	Association	MESH:D007249	24494
33946919	Association	MESH:D002357	171045
33946919	Association	MESH:D007249	60463
33946919	Association	MESH:D010003	60463

